Publications by authors named "Emily Schepers"

Claim this Profile
O
Oncogenic Role of Aberrant EZH2 in Hepatoblastoma.
Kathryn Glaser, Lara Berklite, Brian T Hickner, Priyanka Rao, Roma H Patel, Emily Schepers

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Multi-institutional Data From the Midwest Pediatric Surgery Consortium (MWPSC) to Assess the Effect of Delayed Kasai Procedure on Biliary Drainage in Patients With Biliary Atresia.
Zishaan A Farooqui, Stephen J Hartman, Alyssa E Stetson, Emily J Schepers, Karen E Speck

J Pediatr Surg· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Transplantation for Colorectal Liver Metastases.
Emily J Schepers, Stephen J Hartman, Jenna N Whitrock, Ralph C Quillin

Surg Clin North Am· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EZH2 is a key component of hepatoblastoma tumor cell growth.
Kathryn Glaser, Emily J Schepers, Harrison M Zwolshen, Charissa M Lake, Nikolai A Timchenko

Pediatr Blood Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural and Functional Impact of Posttranslational Modification of Glypican-3 on Liver Carcinogenesis.
Emily J Schepers, Kathryn Glaser, Harrison M Zwolshen, Stephen J Hartman, Alexander J Bondoc

Cancer Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life Outcomes for Patients Who Underwent Conventional Resection and Liver Transplantation for Locally Advanced Hepatoblastoma.
Zishaan Farooqui, Michael Johnston, Emily Schepers, Nathalie Brewer, Stephen Hartman

Children (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Glypican-3 Cleavage Results in Reduced Cell Proliferation in a Liver Cancer Cell Line.
Emily J Schepers, Charissa Lake, Kathryn Glaser, Alexander J Bondoc

J Surg Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimally Invasive Surgery for Resectable Adrenocortical Carcinoma: A Nationwide Analysis.
Aaron M Delman, Kevin M Turner, Azante Griffith, Emily Schepers, Allison M Ammann

J Surg Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-catenin cancer-enhancing genomic regions axis is involved in the development of fibrolamellar hepatocellular carcinoma.
Ruhi Gulati, Michael Johnston, Maria Rivas, Ashley Cast, Meenasri Kumbaji, Emily Schepers

Hepatol Commun· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The volume-outcomes relationship in donation after circulatory death liver transplantation.
Aaron M Delman, Kevin M Turner, Allison M Ammann, Emily Schepers, Dennis M Vaysburg

Clin Transplant· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis.
Xiaoqiang Qi, Emily Schepers, Diego Avella, Eric T Kimchi, Jussuf T Kaifi

J Vis Exp· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer.
Marguerite L Palisoul, Jeanne M Quinn, Emily Schepers, Ian S Hagemann, Lei Guo

Mol Cancer Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis